A 3-Year Follow-Up Study after Treatment with Simeprevir in Combination with Pegylated Interferon-Α and Ribavirin for Chronic Hepatitis C Virus Infection

Fabien Zoulim,Christophe Moreno,Samuel S. Lee,Peter Buggisch,Andrzej Horban,Eric Lawitz,Chris Corbett,Oliver Lenz,Bart Fevery,Thierry Verbinnen,Umesh Shukla,Wolfgang Jessner

Virology journal（2018）

引用 8|浏览23

暂无评分

摘要

Simeprevir is approved with pegylated interferon and ribavirin (PR) for chronic hepatitis C virus (HCV) genotype (GT) 1 and GT4 infection in the USA and the European Union.

查看译文

关键词

Direct-acting antivirals,Hepatitis C virus,Pegylated interferon,Simeprevir,Sustained virologic response,NS3 amino acid substitutions

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要